glp-1 fill finish cdmo Drug Manufacturing: Expansion & Tech Transfer GLP-1 Drugs Changed Peptide Manufacturing
Description
Information on statistical testing is provided in figure legends
10.1038/s12276-018-0183-1 96 ZhouR.LinC.ChengY.ZhuoX.LiQ.XuW.et al (2020)
Understanding that weight maintenance requires ongoing treatment Clinical data consistently shows that stopping GLP-1 medications leads to significant weight regain for most people
Because oral medications rely on absorption through the digestive system, patients may not absorb the full dose as intended
The study also included people who did not plan to take a GLP-1
